Ralf P Brandes1, Katrin Schröder. 1. Institut für Kardiovaskuläre Physiologie, Johann Wolfgang Goethe-Universität, Frankfurt am Main, Germany. r.brandes@em.uni-frankfurt.de
Abstract
PURPOSE OF REVIEW: Reactive oxygen species have been implicated in the initiation and progression of atherosclerosis. Reactive oxygen species can oxidize lipoproteins, limit the vascular availability of antiatherosclerotic nitric oxide and promote vascular expression of cytokines and adhesion molecules. Nox proteins of the NADPH oxidase family are prominent sources of vascular reactive oxygen species, and Nox protein-dependent reactive oxygen species production has been linked to atherogenesis. Recently, significant progress has been made in the understanding of differences among the Nox proteins. RECENT FINDINGS: Nox proteins exhibit cell-specific expression patterns and divergent molecular mechanisms controlling activity have been identified for individual Nox proteins. These aspects may relate to cellular activation, differentiation, proliferation, angiogenesis and gene expression, and may also be modulated by the functional states of the vessel such as endothelial dysfunction: in quiescent vessels, Nox proteins contribute to signal transduction and to the physiological responses to growth factors such as vascular endothelial growth factor or thrombin. Excessive Nox-dependent reactive oxygen species formation in vascular disease such as hyperlipidemia or diabetes, however, largely contributes to vascular dysfunction resulting in defective angiogenesis and inflammatory activation. SUMMARY: Reactive oxygen species, specifically generated by individual Nox proteins, act as secondary messengers. Selective inhibition of Nox proteins might be a novel approach to prevent and treat cardiovascular diseases.
PURPOSE OF REVIEW: Reactive oxygen species have been implicated in the initiation and progression of atherosclerosis. Reactive oxygen species can oxidize lipoproteins, limit the vascular availability of antiatherosclerotic nitric oxide and promote vascular expression of cytokines and adhesion molecules. Nox proteins of the NADPH oxidase family are prominent sources of vascular reactive oxygen species, and Nox protein-dependent reactive oxygen species production has been linked to atherogenesis. Recently, significant progress has been made in the understanding of differences among the Nox proteins. RECENT FINDINGS:Nox proteins exhibit cell-specific expression patterns and divergent molecular mechanisms controlling activity have been identified for individual Nox proteins. These aspects may relate to cellular activation, differentiation, proliferation, angiogenesis and gene expression, and may also be modulated by the functional states of the vessel such as endothelial dysfunction: in quiescent vessels, Nox proteins contribute to signal transduction and to the physiological responses to growth factors such as vascular endothelial growth factor or thrombin. Excessive Nox-dependent reactive oxygen species formation in vascular disease such as hyperlipidemia or diabetes, however, largely contributes to vascular dysfunction resulting in defective angiogenesis and inflammatory activation. SUMMARY:Reactive oxygen species, specifically generated by individual Nox proteins, act as secondary messengers. Selective inhibition of Nox proteins might be a novel approach to prevent and treat cardiovascular diseases.
Authors: Laura V Gatica; Liliana B Oliveros; Matías F Pérez Díaz; Nora S Domínguez; Miguel W Fornes; María S Gimenez Journal: Eur J Nutr Date: 2011-04-22 Impact factor: 5.614
Authors: Augusto C Montezano; Dylan Burger; Tamara M Paravicini; Andreia Z Chignalia; Hiba Yusuf; Mahmoud Almasri; Ying He; Glaucia E Callera; Gang He; Karl-Heinz Krause; David Lambeth; Mark T Quinn; Rhian M Touyz Journal: Circ Res Date: 2010-03-25 Impact factor: 17.367
Authors: Jessica A Sipkens; Paul A J Krijnen; Nynke E Hahn; Melissa Wassink; Christof Meischl; Desirée E C Smith; René J P Musters; Coen D A Stehouwer; Jan A Rauwerda; Victor W M van Hinsbergh; Hans W M Niessen Journal: Mol Cell Biochem Date: 2011-07-08 Impact factor: 3.396
Authors: Markus M Bachschmid; Stefan Schildknecht; Reiko Matsui; Rebecca Zee; Dagmar Haeussler; Richard A Cohen; David Pimental; Bernd van der Loo Journal: Ann Med Date: 2012-03-01 Impact factor: 4.709
Authors: Matthew R DiStasi; Julie A Mund; H Glenn Bohlen; Steven J Miller; David A Ingram; Michael C Dalsing; Joseph L Unthank Journal: Am J Physiol Heart Circ Physiol Date: 2015-08-21 Impact factor: 4.733
Authors: Nicolle Kränkel; Stephen Paul Armstrong; Craig Alexander McArdle; Colin Dayan; Paolo Madeddu Journal: PLoS One Date: 2010-06-17 Impact factor: 3.240